ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,903Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 944

$705K Total Retail Price of All Prescriptions

Rank: 67 out of 944

616 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,855 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 523 468 1 2
PRAVASTATIN SODIUM 520 489 2 17
SIMVASTATIN 489 448 3 1
AMLODIPINE BESYLATE 443 443 4 5
HYDROCHLOROTHIAZIDE 359 342 5 9
LISINOPRIL 350 323 6 3
LOSARTAN POTASSIUM 287 278 7 16
METOPROLOL TARTRATE 274 259 8 8
ATORVASTATIN CALCIUM 247 241 9 13
WARFARIN SODIUM 241 230 10 7
HYDROCODONE-ACETAMINOPHEN 236 218 S3 11 10
FUROSEMIDE 231 224 12 6
METOPROLOL SUCCINATE 201 179 13 14
OMEPRAZOLE 189 180 14 4
ATENOLOL 176 173 15 11
CLOPIDOGREL 161 159 16 36
ALLOPURINOL 142 142 17 22
SPIRONOLACTONE 139 135 18 44
POTASSIUM CHLORIDE 119 116 19 15
CITALOPRAM HBR 119 114 19 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 114 21 29
METFORMIN HCL ER 108 92 22 49
TERAZOSIN HCL 107 107 23 99
DONEPEZIL HCL 105 105 24 24
OXYCODONE HCL 104 56 S2 25 50
DIGOXIN 98 89 26 39
SYNTHROID 97 96 27 82
CRESTOR 94 91 28 28
KLOR-CON M20 90 78 29 71
LANTUS SOLOSTAR 88 67 30 61
PLAVIX 88 86 30 55
GABAPENTIN 85 75 32 18
CARVEDILOL 80 79 33 30
PROAIR HFA 79 73 34 56
PREDNISONE 76 74 35 32
GLIPIZIDE 76 74 35 51
ALENDRONATE SODIUM 75 75 37 20
NAMENDA 75 75 37 37
TRAMADOL HCL 72 66 39 21
METFORMIN HCL 71 55 40 12
NEXIUM 70 54 41 53
ZETIA 68 64 42 59
LEVOFLOXACIN 68 64 42 117
FLUTICASONE PROPIONATE 66 60 44 40
PANTOPRAZOLE SODIUM 66 63 44 34
ADVAIR DISKUS 65 60 46 31
OXYCODONE-ACETAMINOPHEN 65 41 S2 46 62
TRIAMCINOLONE ACETONIDE 63 59 48 105
SERTRALINE HCL 60 59 49 23
GLIPIZIDE XL 59 53 50 136
COMBIVENT 58 58 51 107
ZOLPIDEM TARTRATE 54 47 52 25
RANITIDINE HCL 53 52 53 42
BUMETANIDE 53 47 53 104
OXYCONTIN 53 0 S2 53 92
FINASTERIDE 52 52 56 83
PAROXETINE HCL 51 46 57 64
GLIPIZIDE ER 51 36 57 89
DILTIAZEM 24HR CD 51 50 57 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.